Disease Evaluation Apps on Heidelberg Engineering's Appway

RetinAI provides disease evaluation apps for some of the most common vision-threatening diseases in Ophthalmology.
Enhance, Actionable insights can be generated for the following diseases:

Age-Related Macular Degeneration (AMD)

Enhanced insights for both dry and wet AMD. Dry AMD is a gradual degeneration of central retinal tissue making up the macula. Wet AMD is characterized by leakage, or bleeding, of abnormal blood vessels under the macula. The dry form of AMD can develop into wet AMD, where the disease and impact of vision loss can progress rapidly.

Diabetic Retinopathy (DR)

An eye condition that potentially causes vision loss to patients with diabetes. DR causes damage to the blood vessels of the retina. Different complications may include swelling and leakage of fluid and in other cases, abnormal, new blood vessels growing on the retinal surface.

Diabetic Macular Edema (DME)

A serious complication of diabetes where tiny micro-aneurysms protrude the vessels walls, leaking fluid and blood into the retina. This condition may cause swelling (edema) in the macula, leading to vision loss and blindness.

Retinal Vein Occlusion (RVO)

A blockage of the small veins in the retina. This blockage causes blood and fluid to spill into the retina where the macula can swell from this fluid, affecting central vision. Without blood circulation, nerve cells in the eye may die, eventually causing vision loss to patients.

Disease Evaluation Apps Powered by Certified AI Models

A set of CE-Marked Al models validated and approved for clinical use. These models provide valuable insights for patient management.
‍

Fluid Segmentation

Identifies and quantifies the volume of pathological fluid such as intraretinal fluid (IRF), subretinal fluid (SRF) and pigment epithelium detachment (PED).